Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1741111Generated: October 29, 2026

2'-Methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxylic acid → 2,3,5,6,7,8-Hexahydro-1'-methyl-5-(2'-methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carbonyl)spiro[furo[2,3-g]quinoline-3,4'-piperidine]

https://huagongshe.com/reaction/1741111

Reaction equation

Participants

RoleNameHCIDCharge
Reactant2'-Methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxylic acidHCID 18690066—
Reactant2,3,5,6,7,8-Hexahydro-1'-methylspiro[furo[2,3-g]quinoline-3,4'-piperidine]HCID 22115885—
Product2,3,5,6,7,8-Hexahydro-1'-methyl-5-(2'-methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carbonyl)spiro[furo[2,3-g]quinoline-3,4'-piperidine]HCID 21833790—

Reaction Steps

The title compound was prepared from 2'-methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxylic acid (D11) and 2,3,5,6,7,8-hexahydro-1'-methylspiro[furo[2,3-g]quinoline-3,4'-piperidine] (D10) using a similar procedure to Example 1 as a white solid (62%). This was converted to its oxalate salt which was obtained as a white solid (mp 187-188° C.) and hydrochloride salt (mp 176-180° C.).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05972951
Source datasetuspto-grants-1999_10
ORD IDord-a71a389ed460438f8a7f42782750a1cc
Source noteuspto-grants-1999_10